Bio-Techne (NASDAQ: TECH) reported Q2 EPS of $0.46, $0.03 better than the analyst estimate of $0.43. Revenue for the quarter came in at $295.9 million versus the consensus estimate of $290.42 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.